Clinical Trials & Medical Discoveries Headlines from PR Newswire

< Go Back

SQI Diagnostics Contracted to Automate Pathogen Detection Assays
BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite
OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer
Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients
A new trial tests a combination of Vitamin C and "core" low dose, chemotherapy to reproduce promising safety and efficacy findings
DNA Test for Congenital Cataracts Leads to Faster, More Accurate Diagnoses of Rare Diseases Linked to Childhood Blindness
Visiting Scientist and Engineer Expand Discoveries at Allen Institute for Brain Science
Madonna Rehabilitation Hospital: NIH And NSF Award Research Grant To Dr. Fager For Wireless Sensor Research
Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite
Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies
Second Sight Argus® II Retinal Prosthesis System Wins Financial Support Agreement in France
Star Lineup Set for MDA Show of Strength Telethon This Labor Day Weekend
Hallmark Channel Features Dr. David Amron and Patient to Discuss Lipedema
Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc.
Debbie's Dream Foundation's New York Chapter President to Climb Mount Kilimanjaro
Trovagene Provides Update on Its Urine-Based HPV Test
Analysis Of Available Data From Optimeyes Study (Blinded And Open Label) Of Optina™ For The Treatment Of Diabetic Macular Edema (DME) Indicates Potential For Significant Clinical Benefit
Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody
KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema
Journal of the American Medical Association Publishes New Study Offering Further Validation for Newborn Screening for SCID, a Life-Threatening Primary Immune Disorder
Research study at Banner MD Anderson Cancer Center tests new drug to fight BRCA-associated breast cancer
Scientific Data Supports Superiority of Pivotal's Unique Omega-3 Formulation
ViaCyte, Inc. Announces FDA Acceptance of IND to Commence Clinical Trial of VC-01™ Candidate Cell Replacement Therapy for Type 1 Diabetes
Oramed Granted Patent in Spain for Oral Administration of Insulin
DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer
Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting
Actavis Announces Positive Topline Results From The Phase III Program Of Ceftazidime-Avibactam In Patients With Complicated Intra-Abdominal Infections(cIAI)
iCo Therapeutics Announces Positive Oral Amphotericin B Study Results
Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis
New Research by Wellesley Neuroscientist Shows Blood Cells Generate Neurons in Crayfish; Could Have Implications for Treatment of Neurodegenerative Disorders
Lung Cancer Alliance Applauds Launch of Innovative Trial at National Cancer Institute
UMDF Launches Mitochondrial Disease Community Registry
PCORI Offers Up to $90 Million in Funding in Third Call for Large Pragmatic Studies Proposals
WaferGen Announces Appointment of Chief Operating Officer and Chief Financial Officer
Human Brain Deficits of PKCe: Targeted for Alzheimer's Disease Therapeutic and Diagnostic Trials
Ampio Announces Very Positive Results of the Open Label Portion of the Multiple Intra-articular Injections Study of Ampion™ in Patients with Osteoarthritis of the Knee at Week Six of the Trial
Clinical Study Shows Neo40 Nitric Oxide Supplement Reduces High Blood Pressure and Prehypertension
New Life Sciences Research Reveals Early Stage Treatments to Help Scientists in the Fight against Ebola
Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics
Miami doctor recruited to help fight Ebola in West Africa
LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy
Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint In Pivotal Pharmacokinetic Clinical Study Spanish Portuguese Spanish
FDA Accepts CorMedix, Inc. Pivotal Phase 3 Study Protocol
NeoGenomics Announces Public Offering of Common Stock
Leading ALS Researcher Joins the Kansas City University of Medicine and Biosciences
Alexza Pharmaceuticals Provides an Update on the Five Post-EMA Approval Studies for ADASUVE®
Syneron Medical Introduces New FDA-Cleared 5mm Spot Size for Treatment of Onychomycosis
New Kalorama Report Says In Vitro Diagnostic Market Reaches 54.6 Billion
GenSpera to Present at Rodman & Renshaw 16th Annual Global Investment Conference

< Prev Next >
PR Newswire - United Business Media